SAVE Savencia SA
Savencia SA produces, distributes, and markets dairy and cheese products in France, the Rest of Europe, and internationally. The company offers cheese, butter, creams, and dairy ingredients and nutritional solutions for the retail market and food services market. It offers its products under the Caprice des Dieux, Saint Albray, Le Rustique, Cur de Lion, blue chesses, such as Saint Agur, Bresse Bleu, and PDO Roquefort Papillon; fresh cheeses, such as St-Morêt, Tartare, Carré Frais, Apérivrais; goat cheese, including Chavroux, Saint-Loup, RichesMonts raclette, Géramont, Saint Albray, Fol Epi, Bresso, Milkana, Brunch, Île-de-France, Milkaut, Santa Rosa, Delaco, Kral Syru, Lucina, Medve, Alouette, Rogue Creamery, Polenghi, Corman, and Elle & Vire brands. The company was formerly known as Bongrain SA and changed its name to Savencia SA in April 2015. Savencia SA was founded in 1956 and is headquartered in Viroflay, France. Savencia SA operates as a subsidiary of Savencia Holding.…
Industry Peers
Packaged FoodsKey Statistics
About Savencia (EPA: SAVE)
›
Savencia (EPA: SAVE) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 22,680 employees.
The shares were at 58.80 EUR on 20 November 2026, up 1.4% over 52 weeks. Its 52-week range is 54.20 EUR to 74.40 EUR: the price is 21.0% below the high and 8.5% above the low.
At a market capitalisation of 758.53M EUR, it trades at 10.3 times trailing earnings and 4.7 times forward earnings. The median trailing P/E of its 18 largest Packaged Foods peers is 24.8, a discount of 58% for SAVE. It pays a dividend yielding 2.41% (it pays out 25% of its earnings), against a median of 3.60% among the dividend payers in that peer group.
Savencia reports return on equity of 4.4%, an operating margin of 2.8% and revenue up 2.6% year over year.
Its debt exceeds its cash by 967.50M EUR, a debt-to-equity ratio of 0.74. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 79.00 EUR is 34.4% above the current price.